Valneva SE

NASDAQ:VALN

Biotechnology

Healthcare
$5.34 +0.19%

+$0.01 today

Market cap
$507.98M
Beta
1.40
P/E (TTM)
-2.9
EPS (TTM)
-$0.80
52W Low $5.06High $12.25

Volume 0.00M

Average 0.09M

VALN Sales of Investments

Cash received from selling or redeeming investments.

Valneva SENASDAQ: VALN

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments outflow grows to €437K

Q1 FY2026 sales of investments was €437K, compared with €0 a year earlier. Trailing-twelve-month sales of investments was €1.39M.

Context

  • Sales of investments amounted to 0.5% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near €437K or moves back toward the trailing-twelve-month quarterly average of €347.44K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
€437K-54.1% QoQ
Last fiscal yearDec 2025
€841K— YoY
LTMMar 2026
€1.39M— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

EUR · from the cash flow

Latest · FY2025
841K EUR
Year-over-year change
—

Sales of Investments vs competitors

How VALN compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
  • Sales of investments amounts to 0.9% of revenue for VALN, versus a peer median of 205.1%.
VALN Competitors
Sales of Investments for VALN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MRNAModerna, Inc.LTM Sep 2026$5.45B USD-34.0%+5.7%215.6%
PCVXVaxcyte, Inc.LTM Jun 2026$1.96B USD+26.8%+110.4%—
VIRVir Biotechnology, Inc.LTM Mar 2026$1.07B USD-26.1%+50.6%1633.7%
NVAXNovavax, Inc.LTM Mar 2026$458.02M USD-5.9%—76.8%
IBRXImmunityBio, Inc.LTM Sep 2026$374.39M USD+1501.0%—205.1%
INOInovio Pharmaceuticals, Inc.LTM Mar 2026$24.88M USD-76.0%-62.3%—
VALNValneva SELTM Mar 2026€1.39M EUR——0.9%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding VALN) —-16.0%+28.2%205.1%

Competitors are the stored peer set for VALN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(73.43M)(143.28M)(101.43M)(12.25M)(115.19M)
Depreciation & Amortization14.28M21.04M17.58M19.59M21.75M
Deferred Income Tax3.45M(1.54M)2.8M761K1.07M
Stock-Based Compensation14.51M(8.66M)5.11M7.98M9.53M
Change in Working Capital36.13M(145.98M)(145.06M)(11.57M)(148K)
Accounts Receivables(21.35M)12.4M(2.86M)15.71M13.33M
Inventory(92.37M)84.22M(9.17M)(6.8M)1.03M
Accounts Payables35.24M(14.05M)(17.4M)00
Other Working Capital114.61M(228.55M)(115.65M)(20.48M)(14.51M)
Other Non-Cash Items81.96M33.07M18.25M(71.72M)30.09M
Operating Cash Flow76.9M(245.34M)(202.74M)(67.22M)(52.89M)
Capital Expenditures(93.17M)(29.32M)(14.31M)(16.44M)(4.48M)
Acquisitions (Net)08K(10.95M)00
Purchases of Investments00000
Sales of Investments0000841K
Other Investing Activities55K260K4.6M90.78M1.87M
Investing Cash Flow(93.12M)(29.05M)(20.59M)76.92M(1.71M)
Debt Repayment(3.9M)34.49M75.89M(6.49M)61K
Common Stock Issued166.82M189.84M0030M
Common Stock Repurchased00(240K)00
Dividends Paid00000
Other Financing Activities(8.42M)(9.21M)(12.57M)(19.97M)(30.69M)
Financing Cash Flow154.5M215.12M63.08M30.68M(621K)
Effect of Forex Changes3.96M(828K)(204K)1.81M(3.4M)
Net Change in Cash142.29M(57.21M)(160.45M)42.19M(58.62M)
Free Cash Flow(16.27M)(274.67M)(217.06M)(83.66M)(57.38M)

Valneva SE

NASDAQ:VALN

Intrinsic Alpha fair value

Locked

Current Price

$5.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.